Partly in light of three new Arm Cortex CPUs launching at Computex in June, Chris Bergey, Arm Senior Vice President and ...
A recent report warns that if Canadian businesses don't accelerate generative AI adoption, they risk falling behind. Will the ...
The symposium served as a unique platform for the exchange of cutting-edge ideas and strategies, emphasizing a multi-vector, ...
As previously announced, IMUNON plans to hold an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) in person to discuss the design for a Phase 3 pivotal study of IMNN-001 in ...